非编码 RNA 在肾脏疾病中的作用。
The Role of Non-Coding RNAs in Kidney Diseases.
机构信息
HEMATIM UR 4666, C.U.R.S, Université de Picardie Jules Verne, CEDEX 1, 80025 Amiens, France.
Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Hospital Universitario Reina Sofía, 14004 Cordoba, Spain.
出版信息
Int J Mol Sci. 2022 Jun 14;23(12):6624. doi: 10.3390/ijms23126624.
Abstract
Renal diseases include different pathologies, such as acute kidney injury (AKI), chronic kidney disease (CKD), end-stage renal disease (ESRD), diabetic nephropathy (DN), kidney cancer, polycystic kidney disease, etc [...].
摘要
肾脏疾病包括多种病理，如急性肾损伤 (AKI)、慢性肾脏病 (CKD)、终末期肾病 (ESRD)、糖尿病肾病 (DN)、肾肿瘤、多囊肾病等[... ]。
相似文献
1
The Role of Non-Coding RNAs in Kidney Diseases.非编码 RNA 在肾脏疾病中的作用。
Int J Mol Sci. 2022 Jun 14;23(12):6624. doi: 10.3390/ijms23126624.
2
Fibrotic Changes Mediating Acute Kidney Injury to Chronic Kidney Disease Transition.介导急性肾损伤向慢性肾脏病转变的纤维化改变。
Nephron. 2017;137(4):264-267. doi: 10.1159/000474960. Epub 2017 Jun 9.
3
Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure.急性肾损伤：肾小管标志物与慢性肾脏病及终末期肾衰竭风险
Blood Purif. 2016;41(1-3):144-50. doi: 10.1159/000441269. Epub 2016 Jan 15.
4
Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.在晚期糖尿病肾病中，将肾脏病理评分纳入肾衰竭风险方程的价值。
PLoS One. 2018 Jan 16;13(1):e0190930. doi: 10.1371/journal.pone.0190930. eCollection 2018.
5
The influence of multiple episodes of acute kidney injury on survival and progression to end stage kidney disease in patients with chronic kidney disease.多次急性肾损伤对慢性肾脏病患者生存和进展至终末期肾病的影响。
PLoS One. 2019 Jul 18;14(7):e0219828. doi: 10.1371/journal.pone.0219828. eCollection 2019.
6
Research Progress of Pyroptosis in Renal Diseases. pyroptosis 相关肾脏疾病的研究进展
Curr Med Chem. 2024;31(40):6656-6671. doi: 10.2174/0109298673255656231003111621.
7
Acute Kidney Injury to Chronic Kidney Disease Transition.急性肾损伤向慢性肾脏病的转变
Contrib Nephrol. 2018;193:45-54. doi: 10.1159/000484962. Epub 2018 Jan 23.
8
The role of IL-10 in kidney disease.白细胞介素-10 在肾脏疾病中的作用。
Int Immunopharmacol. 2022 Jul;108:108917. doi: 10.1016/j.intimp.2022.108917. Epub 2022 Jun 3.
9
Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition.急性肾损伤向慢性肾病转变过程中的表观遗传变化
Nephron. 2017;137(4):256-259. doi: 10.1159/000476078. Epub 2017 Jun 9.
10
Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease.伴有或不伴有慢性肾脏病的危重症患者的长期死亡率及终末期肾病发生的危险因素
Crit Care. 2015 Nov 3;19:383. doi: 10.1186/s13054-015-1101-8.
引用本文的文献
1
Molecular Crosstalk Between SIRT1, Wnt/β-Catenin Signaling, and Inflammatory Pathways in Renal Transplant Rejection: Role of miRNAs, lncRNAs, IL-1, IL-6, and Tubulointerstitial Inflammation.肾移植排斥反应中SIRT1、Wnt/β-连环蛋白信号通路与炎症通路之间的分子串扰：微小RNA、长链非编码RNA、白细胞介素-1、白细胞介素-6及肾小管间质炎症的作用
Medicina (Kaunas). 2025 Jun 11;61(6):1073. doi: 10.3390/medicina61061073.
2
Insights into non-coding RNAS: biogenesis, function and their potential regulatory roles in acute kidney disease and chronic kidney disease.非编码RNA研究进展：生物合成、功能及其在急性肾损伤和慢性肾脏病中的潜在调控作用
Mol Cell Biochem. 2025 Mar;480(3):1287-1304. doi: 10.1007/s11010-024-05083-0. Epub 2024 Aug 7.
本文引用的文献
1
Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease.硫酸吲哚酚与 syndecan-1 及游离型 miR-126 在慢性肾脏病中的相关性研究
Int J Mol Sci. 2021 Sep 29;22(19):10549. doi: 10.3390/ijms221910549.
2
Non-Coding RNAs in Kidney Diseases: The Long and Short of Them.非编码 RNA 在肾脏疾病中的作用：长链非编码 RNA 和短链非编码 RNA。
Int J Mol Sci. 2021 Jun 4;22(11):6077. doi: 10.3390/ijms22116077.
3
Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease.长链非编码RNA与微小RNA之间的相互作用影响糖尿病及糖尿病肾病的疾病表型。
Int J Mol Sci. 2021 Jun 2;22(11):6027. doi: 10.3390/ijms22116027.
4
Inhibition of Lysine 63 Ubiquitination Prevents the Progression of Renal Fibrosis in Diabetic DBA/2J Mice.赖氨酸 63 泛素化抑制可防止糖尿病 DBA/2J 小鼠的肾纤维化进展。
Int J Mol Sci. 2021 May 14;22(10):5194. doi: 10.3390/ijms22105194.
5
Non-Coding RNAs in Hereditary Kidney Disorders.非编码 RNA 在遗传性肾脏疾病中的作用。
Int J Mol Sci. 2021 Mar 16;22(6):3014. doi: 10.3390/ijms22063014.
6
MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application.慢性肾脏病中的 microRNAs：4 个具有临床应用潜力的候选分子
Int J Mol Sci. 2020 Sep 7;21(18):6547. doi: 10.3390/ijms21186547.
7
Increased miR-7641 Levels in Peritoneal Hyalinizing Vasculopathy in Long-Term Peritoneal Dialysis Patients.长期腹膜透析患者腹膜玻璃样变血管病中 miR-7641 水平升高。
Int J Mol Sci. 2020 Aug 13;21(16):5824. doi: 10.3390/ijms21165824.
8
Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients.血清 miR-126 和 miR-223 水平与慢性肾脏病患者的结局。
Sci Rep. 2019 Mar 14;9(1):4477. doi: 10.1038/s41598-019-41101-8.
9
The expanding roles of microRNAs in kidney pathophysiology.微小 RNA 在肾脏病理生理学中的作用不断扩大。
Nephrol Dial Transplant. 2019 Jan 1;34(1):7-15. doi: 10.1093/ndt/gfy140.
10
The systemic nature of CKD.CKD 的系统性。
Nat Rev Nephrol. 2017 Jun;13(6):344-358. doi: 10.1038/nrneph.2017.52. Epub 2017 Apr 24.
Zotero 插件